Eupraxia Pharmaceuticals Ownership | Who Owns Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals Ownership Summary
Eupraxia Pharmaceuticals is owned by 52.70% institutional investors, 14.80% insiders, and 32.50% retail investors. Beutel, goodman is the largest institutional shareholder, holding 9.18% of EPRX shares.
EPRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Eupraxia Pharmaceuticals | 52.70% | 14.80% | 32.50% |
| Sector | Healthcare Stocks | 35.38% | 11.35% | 53.27% |
| Industry | Biotech Stocks | 33.91% | 11.39% | 54.70% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Beutel, goodman | 3.67M | 9.18% | $26.38M |
| Affinity asset advisors | 1.59M | 3.98% | $11.50M |
| Balyasny asset management | 1.35M | 3.38% | $9.77M |
| Vivo capital | 1.35M | 3.38% | $9.77M |
| Scotia capital | 1.34M | 3.36% | $7.24M |
| Ikarian capital | 1.21M | 3.04% | $8.79M |
| Great point partners | 1.20M | 3.00% | $8.69M |
| Point72 asset management | 967.58K | 2.42% | $7.01M |
| Ubs group | 762.63K | 1.91% | $5.52M |
| Redmile group | 700.00K | 1.75% | $5.07M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Great point partners | 1.20M | 2.00% | $8.69M |
| Velan capital investment management lp | 352.00K | 1.60% | $2.55M |
| Vivo capital | 1.35M | 0.82% | $9.77M |
| Ikarian capital | 1.21M | 0.71% | $8.79M |
| Affinity asset advisors | 1.59M | 0.59% | $11.50M |
| Aisling capital management lp | 325.00K | 0.49% | $2.35M |
| Pfm health sciences, lp | 540.87K | 0.36% | $3.92M |
| Redmile group | 700.00K | 0.34% | $5.07M |
| Beutel, goodman | 3.67M | 0.18% | $26.38M |
| Persistent asset partners | 37.93K | 0.10% | $274.58K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Affinity asset advisors | 1.59M | 0.59% | 1.29M |
| Redmile group | 700.00K | 0.34% | 700.00K |
| Rubric capital management lp | 691.17K | 0.05% | 691.17K |
| Ikarian capital | 1.21M | 0.71% | 604.74K |
| Ubs group | 762.63K | 0.00% | 542.61K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Arrowstreet capital, limited partnership | - | - | -278.06K |
| Acadian asset management | 93.60K | 0.00% | -62.17K |
| Quadrature capital | - | - | -43.19K |
| Beutel, goodman | 3.67M | 0.18% | -42.91K |
| Xtx topco | - | - | -16.18K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Redmile group | 700.00K | 0.34% | 700.00K | $5.07M |
| Rubric capital management lp | 691.17K | 0.05% | 691.17K | $5.00M |
| Pfm health sciences, lp | 540.87K | 0.36% | 540.87K | $3.92M |
| Ameriprise financial | 524.26K | 0.00% | 524.26K | $3.80M |
| Woodline partners lp | 440.55K | 0.01% | 440.55K | $3.19M |
Sold Out
| Holder | Change |
|---|---|
| Xtx topco | -16.18K |
| Quadrature capital | -43.19K |
| Arrowstreet capital, limited partnership | -278.06K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 52 | 48.57% | 21,056,130 | 52.24% | 52 | 3.09% | 39 | 77.27% | 6 | 50.00% |
| Dec 31, 2025 | 11 | -59.26% | 1,888,543 | -85.26% | 5 | 0.39% | 7 | -68.18% | - | -100.00% |
| Sep 30, 2025 | 27 | 92.86% | 12,813,323 | 550.40% | 38 | 127.17% | 22 | 144.44% | 2 | -60.00% |
| Jun 30, 2025 | 14 | 27.27% | 1,970,076 | -9.11% | 5 | 14.87% | 9 | 12.50% | 5 | 150.00% |
| Mar 31, 2025 | 11 | 22.22% | 2,167,593 | 18.69% | 6 | 23.11% | 8 | 100.00% | 2 | -50.00% |
EPRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools